Time is not always on our side, especially when facing a serious illness such as cancer. At the UCCCC, we understand that patients need cures and they need them now. Our world-renowned physicians and scientists are spending every moment thinking of new ways to bring patients the latest, most effective cancer treatments. Every moment counts — because no one has time to let cancer stop them from living life to the fullest.
“Although progress has been made,
there are still too many people whose
lives are cut short by cancer.”
Kunle Odunsi, MD, PhD
Cancer is a disease that robs people of time. Although progress has been made, there are still too many people whose lives are cut short by cancer. That is why we are working hard to bring laboratory discoveries to patients sooner. As a national leader in cancer research and care, we are focused exclusively on finding ways to stop cancer so that people live long, healthy lives. Below are highlights of the research and clinical advances that our physicians, scientists and staff have made in the span of a year.
Kunle Odunsi, MD, PhD
Director, University of Chicago Medicine Comprehensive Cancer Center
Plus, top “high performing” rating in colon cancer surgery, lung cancer surgery, ovarian cancer surgery, and prostate cancer surgery.View article
new cancer patients served (in 2021)
cancer-related published manuscripts
aspiring scientists got hands-on lab experience
events for the community
We put patients at the center of everything and look to improve every aspect of the cancer journey.
Scientific discoveries bring us closer to new and better treatments with fewer side effects.
Our programs give students a jump-start on careers in cancer research and care.
Cancer outcomes in Chicago are worse than the national average. We are working with the community to address cancer disparities and promote health equity.
Our investigators were recognized for their contributions to the study and treatment of cancer, as well as extraordinary leadership.
This report describes important details about our pediatric and adult patient population, such as types of cancers diagnosed and/or treated, and their geographic and demographic make-up.